Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Search

Transforming Care Through Actionable Biomarkers

BioPorto is dedicated to providing clinicians with tools to make impactful changes in patient management; currently, the NGAL biomarker to aid in the risk assessment and diagnosis of acute kidney injury.

Acute Kidney Injury is a Silent Epidemic

The current standard of care for assessing AKI in critically ill patients relies on changes in serum creatinine and urine output, physiologic endpoints that are delayed, non-specific, and impacted by extrarenal
factors such as nutritional status and muscle mass.iii
Learn More About AKI

Empowering Early Intervention

Rapidly detect acute kidney injury with The NGAL Test™. Unlike traditional methods, an NGAL result identifies kidney damage early, guiding interventions with the potential to prevent irreversible damage. Take confident action now.

About The NGAL Test

*The NGAL Test is CE-marked and available for in vitro diagnostic use in the EU. It is registered in Canada, Korea, Israel and other countries.

Revolutionizing Pediatric AKI Risk Assessment

BioPorto welcomes ProNephro AKI (NGAL) to its family of NGAL products in the race against kidney damage – the first FDA-cleared biomarker for pediatric acute kidney injury risk assessment. US commercial availability through Roche Diagnostics is expected in 2024.

About Pronephro AKI

*ProNephro AKI is FDA-cleared for use in the US. Commercial availability expected in 2024.

Supporting Research

BioPorto offers a unique range of human and animal NGAL ELISA kits for preclinical animal research and Phase 1 human clinical trials.

About NGAL elisa kits

Join us in changing the kidney care paradigm

Stay up to date with the latest resources for kidney care, and news about BioPorto.

Additional Resources

Kidney Disease: Improving Global Outcomes

KDIGO develops and implements evidence-based clinical practice guidelines in kidney disease.

Acute Dialysis Quality Initiative

The ADQI develops a consensus of opinion regarding acute renal failure best practices and articulates a research agenda to focus on unanswered questions.

World Kidney Day

A global campaign to raise awareness about the importance of our kidneys.

International Society of Nephrology

The ISN is passionately focused on improving kidney health globally with access to treatment for all.

International Federation of Kidney Foundations

A leader in the prevention and treatment of kidney disease through the development and support of kidney foundations worldwide.

European Renal Association-European Dialysis and Transplantation Association

The ERA-EDTA’s mission is to advance medical science in the fields of nephrology, dialysis, renal transplantation, and related subjects.

National Kidney Foundation

The NKF is dedicated to the awareness, prevention and treatment of kidney disease for healthcare professionals, patients, and their families, and those at risk.

American Society of Nephrology

Through education, research and advocacy, the ASN leads the fight to prevent, treat and cure kidney diseases globally.